Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2018 Filed Apr 18, 2018 00:24 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 285,700 | $3.50 | $999,950.00 |
DisclosureSEC source: 0001209191-18-025269 · doc4.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,522,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reflects the cashless exercise of Series B warrants to purchase common stock, at a strike price of $3.50 and a closing market price on the date of exercise of $7.55. The exercise of the Series B warrants is exempt pursuant to Rule 166-3. F2 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 8,103 | $3.84 | $31,115.52 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 5 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,001 F8 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.83 and $3.85. F9 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 6,300 | $3.88 | $24,444.00 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.88 and $3.90. F7 · ownership.direct: The securities are held in the Dick Allen Roth IRA. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 6,300 | $3.89 | $24,507.00 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,300 F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.89 and $3.90. F5 · ownership.nature: The securities are held in the Mary Allen Roth IRA. The Reporting Person is married to Mary Allen, and the Reporting Person may be deemed to have indirect beneficial ownership of such securities held in the Mary Allen Roth IRA. The Reporting Person disclaims beneficial ownership of such securities held in the Mary Allen Roth IRA. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 2,418 | $3.96 | $9,575.28 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,500 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.95 and $3.96. F3 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 2,418 | $3.96 | $9,575.28 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,500 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.95 and $3.96. F2 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBP Jake Allen Gammon.The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 16:56 UTC |
GREENE HOWARD E JRDirector
|
PurchaseCommon Stock | 50,000 | $2.00 | $100,000.00 |
DisclosureSEC source: 0001209191-18-009610 · doc4.xml · nonDerivative · entry 1 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 61,787 F1 · balance_after: The amount of securities beneficially owned following reported transactions is reflective of the 1 for 10 reverse split effected by Tandem Diabetes Care, Inc. on October 9, 2017. F2 · ownership.nature: The securities are held by the Greene Family Trust. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:59 UTC |
ROEDER DOUGLAS ADirector
|
PurchaseCommon Stock | 9,670 | $2.00 | $19,340.00 |
DisclosureSEC source: 0001209191-18-009618 · doc4.xml · nonDerivative · entry 2 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 13,217 F1 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F3 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi BioInvestments VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi BioInvestments VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi BioInvestments VIII, L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:59 UTC |
ROEDER DOUGLAS ADirector
|
PurchaseCommon Stock | 990,330 | $2.00 | $1,980,660.00 |
DisclosureSEC source: 0001209191-18-009618 · doc4.xml · nonDerivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,353,586 F1 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F2 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi Ventures VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi Ventures VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi Ventures VIII, L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:58 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001209191-18-009613 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 13,898 F1 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F3 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:58 UTC |
Allen DickDirector
|
PurchaseCommon Stock | 50,000 | $2.00 | $100,000.00 |
DisclosureSEC source: 0001209191-18-009613 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 63,160 F1 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F2 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:54 UTC |
TWOMEY CHRISTOPHER JDirector
|
PurchaseCommon Stock | 25,000 | $2.00 | $50,000.00 |
DisclosureSEC source: 0001209191-18-009605 · doc4.xml · nonDerivative · entry 2 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 26,758 F1 · shares: The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock. F2 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F4 · ownership.nature: The securities are directly owed by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:54 UTC |
TWOMEY CHRISTOPHER JDirector
|
PurchaseCommon Stock | 50,000 | $2.00 | $100,000.00 |
DisclosureSEC source: 0001209191-18-009605 · doc4.xml · nonDerivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 52,550 F1 · shares: The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock. F2 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F3 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:52 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
PurchaseCommon Stock | 750,000 | $2.00 | $1,500,000.00 |
DisclosureSEC source: 0001209191-18-009597 · doc4.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,236,494 F1 · date: The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock. F2 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 18:01 UTC |
GREENE HOWARD E JRDirector
|
GrantStock Option · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064034 · doc4.xml · derivative · entry 1 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over twelve (12) months. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:58 UTC |
CAHILL EDWARD LDirector
|
GrantStock Option · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064031 · doc4.xml · derivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over twelve (12) months. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 23:06 UTC |
ROEDER DOUGLAS ADirector
|
GrantStock Option · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064038 · doc4.xml · derivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over twelve (12) months. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 23:03 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Option · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064036 · doc4.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over twelve (12) months. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 23:04 UTC |
Allen DickDirector
|
GrantStock Option · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064037 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over twelve (12) months. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 23:00 UTC |
Cohen Fred EDirector
|
GrantStock Option · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064033 · doc4.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over twelve (12) months. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:59 UTC |
Morrison SusanCHIEF ADMINSTRATIVE OFFICER
|
GrantStock Option · Derivative | 80,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064032 · doc4.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:56 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
GrantStock Opotion · Derivative | 100,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064029 · doc4.xml · derivative · entry 1 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:57 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064030 · doc4.xml · derivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 22:55 UTC |
BERGER DAVID BEVP, GEN. COUNSEL & SECRETARY
|
GrantStock Option · Derivative | 80,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064028 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 18:53 UTC |
GREENE HOWARD E JRDirector
|
GrantStock Options · Derivative | 1,700 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001209191-17-061625 · doc4.xml · derivative · entry 1 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 23:41 UTC |
CAHILL EDWARD LDirector
|
GrantStock Options · Derivative | 1,700 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001209191-17-061612 · doc4.xml · derivative · entry 1 CAHILL EDWARD L · CIK 0001025665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 02:39 UTC |
ROEDER DOUGLAS ADirector · 10% owner
|
GrantStock Options · Derivative | 1,700 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001209191-17-061668 · doc4.xml · derivative · entry 1 ROEDER DOUGLAS A · CIK 0001270735 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 18, 2017 00:02 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Options · Derivative | 1,700 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001209191-17-061635 · doc4.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 23:47 UTC |
Cohen Fred EDirector
|
GrantStock Options · Derivative | 1,700 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001209191-17-061618 · doc4.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 23:25 UTC |
Allen DickDirector
|
GrantStock Options · Derivative | 1,700 | $2.54 Strike: $2.54 | $4,318.00 |
DisclosureSEC source: 0001209191-17-061605 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 22:54 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
PurchaseSeries B Warrants to Purchase Common Stock · Derivative | 285,700 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-17-057210 · doc4.xml · derivative · entry 3 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 285,700 Underlying: Common Stock · 285,700 shares Expires 2018-04-17 F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010 Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 22:54 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
PurchaseSeries A Warrants to Purchase Common Stock · Derivative | 285,700 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-17-057210 · doc4.xml · derivative · entry 2 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 285,700 Underlying: Common Stock · 285,700 shares Expires 2022-10-17 F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010 Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 22:54 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
PurchaseCommon Stock | 285,700 | $3.50 | $999,950.00 |
DisclosureSEC source: 0001209191-17-057210 · doc4.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 486,494 F1 · date: The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock. F2 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010 Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:58 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
GrantStock Options · Derivative | 315,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033628 · doc4.xml · derivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,000 Underlying: Common Stock · 315,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:07 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
GrantStock Options · Derivative | 105,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033638 · doc4.xml · derivative · entry 1 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:04 UTC |
Morrison SusanCHIEF ADMINSTRATIVE OFFICER
|
GrantStock Options · Derivative | 105,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033636 · doc4.xml · derivative · entry 2 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F4 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:03 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
GrantStock Options · Derivative | 105,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033634 · doc4.xml · derivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F4 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:01 UTC |
Cajigas JohnEVP, CFO & TREASURER
|
GrantStock Options · Derivative | 105,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033633 · doc4.xml · derivative · entry 3 Cajigas John · CIK 0001582797 · EVP, CFO & TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F4 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F5 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 17, 2017 Filed May 18, 2017 21:00 UTC |
BERGER DAVID BEVP, GEN. COUNSEL & SECRETARY
|
GrantStock Options · Derivative | 105,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001209191-17-033630 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 25% on 5/17/2018 and the remainder in 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 15, 2017 Filed May 18, 2017 21:04 UTC |
Morrison SusanCHIEF ADMINSTRATIVE OFFICER
|
GrantCommon Stock | 12,501 | $0.77 | $9,625.77 |
DisclosureSEC source: 0001209191-17-033636 · doc4.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900 F1 · date: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2016 through May 15, 2017. This transaction is also exempt under Rule 16b-3(c). F2 · date: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on May 15, 2017. Read SEC document |
| May 15, 2017 Filed May 18, 2017 21:03 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
GrantCommon Stock | 5,303 | $0.77 | $4,083.31 |
DisclosureSEC source: 0001209191-17-033634 · doc4.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,974 F1 · date: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2016 through May 15, 2017. This transaction is also exempt under Rule 16b-3(c). F2 · date: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on May 15, 2017. Read SEC document |
| May 15, 2017 Filed May 18, 2017 21:01 UTC |
Cajigas JohnEVP, CFO & TREASURER
|
GrantCommon Stock | 10,831 | $0.77 | $8,339.87 |
DisclosureSEC source: 0001209191-17-033633 · doc4.xml · nonDerivative · entry 1 Cajigas John · CIK 0001582797 · EVP, CFO & TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,353 F1 · date: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2016 through May 15, 2017. This transaction is also exempt under Rule 16b-3(c). F2 · date: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on May 15, 2017. Read SEC document |
| March 23, 2017 Filed Mar 24, 2017 00:28 UTC |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
PurchaseCommon Stock | 1,600,000 | $1.25 | $2,000,000.00 |
DisclosureSEC source: 0001209191-17-022685 · doc4.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,007,939 F1 · date: The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock. Read SEC document |
| March 23, 2017 Filed Mar 29, 2017 21:34 UTC Amendment |
BLICKENSTAFF KIM DDirector · PRESIDENT & CEO
|
PurchaseCommon Stock | 1,600,000 | $1.25 | $2,000,000.00 |
DisclosureSEC source: 0001209191-17-023562 · doc4a.xml · nonDerivative · entry 1 BLICKENSTAFF KIM D · CIK 0001238913 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,007,939 F1 · date: The reporting person has committed to purchase shares in connection with the Company's underwritten registered public offering of common stock. F2 · ownership.direct: This amendment is being filed to reflect correctly the total amount of securities beneficially owned indirectly which was inadvertently reported as total amount of securities beneficially owned directly. F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:42 UTC |
Sheridan John FEVP, CHIEF OPERATING OFFICER
|
GrantStock Options · Derivative | 169,200 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-16-155753 · doc4.xml · derivative · entry 1 Sheridan John F · CIK 0001365369 · EVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,200 Underlying: Common Stock · 169,200 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:37 UTC |
BERGER DAVID BEVP, GEN. COUNSEL & SECRETARY
|
GrantStock Options · Derivative | 169,200 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-16-155749 · doc4.xml · derivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, GEN. COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,200 Underlying: Common Stock · 169,200 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:41 UTC |
Morrison SusanCHIEF ADMINSTRATIVE OFFICER
|
GrantStock Options · Derivative | 169,200 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-16-155752 · doc4.xml · derivative · entry 1 Morrison Susan · CIK 0001582970 · CHIEF ADMINSTRATIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,200 Underlying: Common Stock · 169,200 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:40 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
GrantStock Options · Derivative | 112,800 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-16-155751 · doc4.xml · derivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,800 Underlying: Common Stock · 112,800 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 16, 2016 Filed Dec 17, 2016 01:39 UTC |
Cajigas JohnEVP, CFO & TREASURER
|
GrantStock Options · Derivative | 169,200 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-16-155750 · doc4.xml · derivative · entry 1 Cajigas John · CIK 0001582797 · EVP, CFO & TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,200 Underlying: Common Stock · 169,200 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest as to 50% on 12/16/2017 and the remainder in 12 equal monthly installments thereafter. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 20:03 UTC |
GREENE HOWARD E JRDirector
|
GrantStock Options · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-16-150723 · doc4.xml · derivative · entry 1 GREENE HOWARD E JR · CIK 0000903574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.